Fundraising Fox

Eurofarma Ventures

Corporate VC

Seed–Growth

Fox Verdict
Sign up to see your fit
Stage
Seed–Growth
Instruments
Equity
Last 12 months
1 investment
Tracked investments
1

What they invest in

from 1 of 1 portfolio companies

Biotech ×1Healthtech ×1

HQs:United States×1

Investments · 1 tracked

founders shown can be your intro path
Abcuroabcuro.comAug 2026

Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.

BiotechHealthtechNewton, US

Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)

Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesMass General Brigham Ventures+8 more

Portfolio news

latest coverage across their companies

Frequently asked questions

What stage does Eurofarma Ventures invest at?
Eurofarma Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.

Similar investors

Featured in lists